AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

DROSPIRENONE + ETHINYLESTRADIOL

11 registrations across 5 African markets— 9 active

Markets with DROSPIRENONE + ETHINYLESTRADIOL

Recent registrations

Brand / ProductMarketHolderStatusExpires
CONTREZ
TABLET, COATED; ORAL
🇿🇼ZimbabweINNOVATA PHARMACEUTICALSactiveDec 2028
YASTRA 20
TABLET, COATED; ORAL
🇿🇼ZimbabweCOSPHARM INVESTMENTS (PTY) LTDactiveJun 2028
ELLANITE
Comprimé pelliculé / 0.03MG/3MG
🇹🇳TunisiaSTRAGEN UK LimitedexpiredNov 2019
JASMINE
Comprimé pelliculé
🇹🇳TunisiaBAYER HEALTHCARE SAS.FRANCEexpiredJul 2009
DROSPIRENONE + ETHINYLESTRADIOL
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaBAYER SCHERING PHARMAactive
JASMINE
COMPRIME PELLICULE
🇲🇦Moroccoactive
JASMINE
COMPRIME PELLICULE
🇲🇦Moroccoactive
DROSPIRENONE + ETHINYLESTRADIOL
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaBAYER SCHERING PHARMAactive
DROSPIRENONE + ETHINYLESTRADIOL
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaBAYER SCHERING PHARMAactive
Yasmin
Tablets
🇹🇿TanzaniaBayer East Africa Ltdactive
DROSPIRENONE + ETHINYLESTRADIOL
ORAL SOLID ORDINARY TABLETS
🇺🇬UgandaBAYER SCHERING PHARMAactive

DROSPIRENONE + ETHINYLESTRADIOL in Africa — Regulatory Overview

DROSPIRENONE + ETHINYLESTRADIOL is registered across 5 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Morocco, Tunisia, Zimbabwe and 1 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 9 (82%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.